• Profile

Cost-effectiveness of lung cancer screening with low-dose CT in heavy smokers: A microsimulation modelling study

European Journal of Cancer Jul 22, 2020

Du Y, Sidorenkov G, Heuvelmans MA, et al. - In a high-risk population, researchers assessed how cost-effective lung cancer screening with low-dose computed tomography (LDCT) is. An adapted microsimulation model was utilized in a Dutch cohort of heavy smokers for a lifetime horizon from a health insurance perspective. For women, the optimal screening strategy is biennial screening from the age of 50 to 80 years, with a incremental cost-effectiveness ratio of 21.1 k€/life year gained vs no screening, while for men it was annual screening from 55 to 80 years for men incremental cost-effectiveness ratio 27.6 k€/life year gained vs no screening. In a high-risk population, lung cancer LDCT screening was found to be cost-effective, and the best screening scenario is dependent on gender.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen